FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024697318> ?p ?o ?g. }

• W2024697318 endingPage "591" @default.
• W2024697318 startingPage "586" @default.
• W2024697318 abstract "Antimicrobial drug resistance in Neisseria gonorrhoeae has become an increasing public health problem. Hence, surveillance of resistance development is of crucial importance to implement adequate treatment guidelines. Data on the spread of antibiotic resistance among gonococcal isolates in Germany, however, is scarce. In a resistance surveillance study conducted by the Paul Ehrlich Society for Chemotherapy between October 2010 and December 2011, 23 laboratories all over Germany were requested to send N. gonorrhoeae isolates to the study laboratory in Frankfurt am Main. Species verification was performed biochemically using ApiNH and with Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS). Antimicrobial susceptibility testing was performed using the Etest method. For molecular epidemiological analysis, N. gonorrhoeae strains were genotyped by means of N. gonorrhoeae multi-antigen sequence typing. A total of 213 consecutive gonococcal isolates were analyzed in this nationwide study. Applying EUCAST breakpoints, high resistance rates were found for ciprofloxacin (74%) and tetracycline (41%). Penicillin non-susceptibility was detected in 80% of isolates. The rate of azithromycin resistance was 6%, while all strains were susceptible to spectinomycin, cefixime, and ceftriaxone. Molecular typing of gonococcal isolates revealed a great heterogeneity of 99 different sequence types (ST), but ST1407 predominated (n=39). This is the first comprehensive German multi-centre surveillance study on antibiotic susceptibility and molecular epidemiology of N. gonorrhoeae with implications for antibiotic choice for treatment of gonorrhoea. The World Health Organization supports the concept that an efficacious treatment of gonorrhoea results in at least 95% of infections being cured. Accordingly, as spectinomycin is not available on the German market, only the third generation cephalosporins cefixime and ceftriaxone are regarded as valuable drugs for empirical treatment of gonorrhoea in Germany." @default.
• W2024697318 created "2016-06-24" @default.
• W2024697318 creator A5008896502 @default.
• W2024697318 creator A5027980999 @default.
• W2024697318 creator A5053083966 @default.
• W2024697318 creator A5064025633 @default.
• W2024697318 creator A5067364341 @default.
• W2024697318 creator A5079032078 @default.
• W2024697318 date "2014-07-01" @default.
• W2024697318 modified "2023-09-24" @default.
• W2024697318 title "Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany" @default.
• W2024697318 cites W172523583 @default.
• W2024697318 cites W1991177756 @default.
• W2024697318 cites W1994449629 @default.
• W2024697318 cites W1998627183 @default.
• W2024697318 cites W2010906969 @default.
• W2024697318 cites W2041198072 @default.
• W2024697318 cites W2055000681 @default.
• W2024697318 cites W2058828207 @default.
• W2024697318 cites W2067436228 @default.
• W2024697318 cites W2103067793 @default.
• W2024697318 cites W2107709676 @default.
• W2024697318 cites W2109504052 @default.
• W2024697318 cites W2111450162 @default.
• W2024697318 cites W2119904091 @default.
• W2024697318 cites W2123069766 @default.
• W2024697318 cites W2123386797 @default.
• W2024697318 cites W2126587888 @default.
• W2024697318 cites W2144552450 @default.
• W2024697318 cites W2145540472 @default.
• W2024697318 cites W2147292570 @default.
• W2024697318 cites W2149869281 @default.
• W2024697318 cites W2151987387 @default.
• W2024697318 cites W2152718845 @default.
• W2024697318 cites W2158382435 @default.
• W2024697318 cites W2166425896 @default.
• W2024697318 cites W2170093155 @default.
• W2024697318 cites W34855022 @default.
• W2024697318 cites W68503324 @default.
• W2024697318 cites W77459334 @default.
• W2024697318 doi "https://doi.org/10.1016/j.ijmm.2014.04.001" @default.
• W2024697318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24801146" @default.
• W2024697318 hasPublicationYear "2014" @default.
• W2024697318 type Work @default.
• W2024697318 sameAs 2024697318 @default.
• W2024697318 citedByCount "15" @default.
• W2024697318 countsByYear W20246973182015 @default.
• W2024697318 countsByYear W20246973182016 @default.
• W2024697318 countsByYear W20246973182017 @default.
• W2024697318 countsByYear W20246973182018 @default.
• W2024697318 countsByYear W20246973182019 @default.
• W2024697318 countsByYear W20246973182020 @default.
• W2024697318 countsByYear W20246973182022 @default.
• W2024697318 countsByYear W20246973182023 @default.
• W2024697318 crossrefType "journal-article" @default.
• W2024697318 hasAuthorship W2024697318A5008896502 @default.
• W2024697318 hasAuthorship W2024697318A5027980999 @default.
• W2024697318 hasAuthorship W2024697318A5053083966 @default.
• W2024697318 hasAuthorship W2024697318A5064025633 @default.
• W2024697318 hasAuthorship W2024697318A5067364341 @default.
• W2024697318 hasAuthorship W2024697318A5079032078 @default.
• W2024697318 hasConcept C104317684 @default.
• W2024697318 hasConcept C114851261 @default.
• W2024697318 hasConcept C135763542 @default.
• W2024697318 hasConcept C159047783 @default.
• W2024697318 hasConcept C174802600 @default.
• W2024697318 hasConcept C2776520383 @default.
• W2024697318 hasConcept C2778063948 @default.
• W2024697318 hasConcept C2778082588 @default.
• W2024697318 hasConcept C2778243283 @default.
• W2024697318 hasConcept C2779166590 @default.
• W2024697318 hasConcept C3013748606 @default.
• W2024697318 hasConcept C501593827 @default.
• W2024697318 hasConcept C54355233 @default.
• W2024697318 hasConcept C77434933 @default.
• W2024697318 hasConcept C81396022 @default.
• W2024697318 hasConcept C86803240 @default.
• W2024697318 hasConcept C89423630 @default.
• W2024697318 hasConcept C94665300 @default.
• W2024697318 hasConcept C97669555 @default.
• W2024697318 hasConceptScore W2024697318C104317684 @default.
• W2024697318 hasConceptScore W2024697318C114851261 @default.
• W2024697318 hasConceptScore W2024697318C135763542 @default.
• W2024697318 hasConceptScore W2024697318C159047783 @default.
• W2024697318 hasConceptScore W2024697318C174802600 @default.
• W2024697318 hasConceptScore W2024697318C2776520383 @default.
• W2024697318 hasConceptScore W2024697318C2778063948 @default.
• W2024697318 hasConceptScore W2024697318C2778082588 @default.
• W2024697318 hasConceptScore W2024697318C2778243283 @default.
• W2024697318 hasConceptScore W2024697318C2779166590 @default.
• W2024697318 hasConceptScore W2024697318C3013748606 @default.
• W2024697318 hasConceptScore W2024697318C501593827 @default.
• W2024697318 hasConceptScore W2024697318C54355233 @default.
• W2024697318 hasConceptScore W2024697318C77434933 @default.
• W2024697318 hasConceptScore W2024697318C81396022 @default.
• W2024697318 hasConceptScore W2024697318C86803240 @default.
• W2024697318 hasConceptScore W2024697318C89423630 @default.
• W2024697318 hasConceptScore W2024697318C94665300 @default.

• next